CD200 and cerebral artery occlusion: To be able to use the beneficial effect of CD200 signaling in ischemic stroke, Kong et al. (2018) used human mesenchymal stem cells with high CD200 expression from human placenta which they transplanted intracerebrally 24 h after transient middle cerebral artery occlusion (tMCAO).